Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
REVENUES:
Federal grants	$ 578,657
License revenue	200,000	20,000
TOTAL REVENUES	778,657	20,000
OPERATING EXPENSES:
Research and development	4,157,454	78,656
General and administrative	10,174,997	4,752,068
Impairment of intangible assets	2,294,048	0
TOTAL OPERATING EXPENSES	16,626,499	4,830,724
OPERATING LOSS	(15,847,842)	(4,810,724)
OTHER INCOME (EXPENSE)
Interest income	112,377	571
Interest expense	(1,164,897)	(95,125)
Change in fair value of warrant liability	633,631
TOTAL OTHER INCOME (EXPENSE)	(418,889)	(94,554)
LOSS BEFORE INCOME TAX BENEFIT	(16,266,731)	(4,905,278)
Income tax benefit	920,000
NET LOSS	$ (15,346,731)	$ (4,905,278)
Net loss per common share - basic and diluted (in dollars per share)	$ (2.19)	$ (1.12)
Weighted average common shares outstanding - basic and diluted (in shares)	7,020,479	4,383,433